These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration. de Lemos ML; Monfared S; Denyssevych T; Hamata L; Jennings S; Thiessen B; Smith S; Waterhouse D J Oncol Pharm Pract; 2009 Mar; 15(1):45-52. PubMed ID: 18772215 [TBL] [Abstract][Full Text] [Related]
3. A simple technique to reduce preservative/excipient related neurotoxicity of intrathecal (spinal) drugs. Munir MA; Krishnan S; Ahmad M Anesth Analg; 2000 Mar; 90(3):767-8. PubMed ID: 10702476 [No Abstract] [Full Text] [Related]
4. Intrathecal chemotherapy-a word of caution. Siderov J Ann Hematol; 2009 Oct; 88(10):1039. PubMed ID: 19271218 [No Abstract] [Full Text] [Related]
5. Adverse reactions to the non-drug constituents of nebuliser solutions. Beasley R; Rafferty P; Holgate ST Br J Clin Pharmacol; 1988 Mar; 25(3):283-7. PubMed ID: 3358893 [No Abstract] [Full Text] [Related]
6. Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives. Allen LV Int J Pharm Compd; 2019; 23(6):472-477. PubMed ID: 31751944 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate. Cradock JC; Kleinman LM; Rahman A Am J Hosp Pharm; 1978 Apr; 35(4):402-6. PubMed ID: 25579 [TBL] [Abstract][Full Text] [Related]
8. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis. Bozdağ S; Gümüş K; Gümüş O; Unlü N Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953 [TBL] [Abstract][Full Text] [Related]
9. Basics: Excipients Used in Nonsterile Compounding, Part 2. Allen LV Int J Pharm Compd; 2019; 23(5):393-396. PubMed ID: 31513538 [TBL] [Abstract][Full Text] [Related]
13. A pH pattern for I.V. additives. Webb JW Am J Hosp Pharm; 1969 Jan; 26(1):31-5. PubMed ID: 5763886 [No Abstract] [Full Text] [Related]
14. [New drug formulations as the result of recent technological development efforts]. Speiser P Acta Pharm Suec; 1973 Nov; 10(5):381-400. PubMed ID: 4765583 [No Abstract] [Full Text] [Related]
15. [On the stability of parenterals at the time of compounding]. Kodama M; Ogata T Iryo; 1969 Feb; 23(2):269-72. PubMed ID: 5803154 [No Abstract] [Full Text] [Related]
16. Neurotoxicity of intrathecal local anesthetics in rabbits. Ready LB; Plumer MH; Haschke RH; Austin E; Sumi SM Anesthesiology; 1985 Oct; 63(4):364-70. PubMed ID: 3839985 [TBL] [Abstract][Full Text] [Related]
17. The effect of lubricants and mixing on the antacid value of tablets. Jovanović M; Djurić Z; Todorović Z; Kesin B; Backalov L; Radosavljević G Pharmazie; 1988 Dec; 43(12):871-2. PubMed ID: 3247383 [No Abstract] [Full Text] [Related]
18. [On the antimicrobial activity of benzalkonium chloride in potential contact lens fluids]. Jira T; Panzig B; Pohloudek-Fabini R Pharmazie; 1982 Aug; 37(8):587-90. PubMed ID: 7146068 [TBL] [Abstract][Full Text] [Related]
19. Potential clinical impact of compounded versus noncompounded intrathecal baclofen. Moberg-Wolff E Arch Phys Med Rehabil; 2009 Nov; 90(11):1815-20. PubMed ID: 19887203 [TBL] [Abstract][Full Text] [Related]
20. Review of excipients and pH's for parenteral products used in the United States. Wang YC; Kowal RR J Parenter Drug Assoc; 1980; 34(6):452-62. PubMed ID: 6906368 [No Abstract] [Full Text] [Related] [Next] [New Search]